Cargando…

Potential Biomarkers for NSAID-Exacerbated Respiratory Disease

Asthma is a common chronic disease with several variant phenotypes and endotypes. NSAID-exacerbated respiratory disease (NERD) is one such endotype characterized by asthma, chronic rhinosinusitis (CRS) with nasal polyps, and hypersensitivity to aspirin/cyclooxygenase-1 inhibitors. NERD is more assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hanki, Choi, Youngwoo, Jung, Chang-Gyu, Park, Hae-Sim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568600/ https://www.ncbi.nlm.nih.gov/pubmed/28852271 http://dx.doi.org/10.1155/2017/8160148

Ejemplares similares

Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease
por: Rhyou, Hyo-In, et al.
Publicado: (2022)

Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease?
por: Choi, Youngwoo, et al.
Publicado: (2018)

NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care
por: Woo, Seong-Dae, et al.
Publicado: (2020)

Extracellular Vesicles, a Key Mediator to Link Environmental Microbiota to Airway Immunity
por: Choi, Youngwoo, et al.
Publicado: (2017)

Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease
por: Lee, Jong-Uk, et al.
Publicado: (2019)

Potential Metabolic Biomarkers in Adult Asthmatics
por: Sim, Soyoon, et al.
Publicado: (2021)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Clinical Characteristics of NSAID-induced Blended Reaction
por: Hur, Gyu Young, et al.
Publicado: (2021)

Urine Microbial Extracellular Vesicles Can Be Potential and Novel Biomarkers for Allergic Diseases
por: Choi, Youngwoo, et al.
Publicado: (2020)

NSAID-exacerbated respiratory disease: a population study
por: Andersén, Heidi, et al.
Publicado: (2022)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
por: Shrestha Palikhe, Nami, et al.
Publicado: (2012)

Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E(4) production in aspirin-exacerbated respiratory disease
por: Choi, Youngwoo, et al.
Publicado: (2021)

Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009)

Factors Predicting Recovery From Asthma Exacerbations
por: Jung, Chang Gyu, et al.
Publicado: (2016)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease
por: Sillanpää, Saara, et al.
Publicado: (2021)

Risk factors of NSAID‐exacerbated respiratory disease: A population‐based study
por: Helevä, Alma, et al.
Publicado: (2023)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Bacterial Extracellular Vesicles: A Candidate Molecule for the Diagnosis and Treatment of Allergic Diseases
por: Choi, Youngwoo, et al.
Publicado: (2023)

Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications
por: Choi, Youngwoo, et al.
Publicado: (2020)

Immunologic Basis of Type 2 Biologics for Severe Asthma
por: Sim, Soyoon, et al.
Publicado: (2022)

Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2016)

Extracellular Traps: A Novel Therapeutic Target for Severe Asthma
por: Choi, Youngwoo, et al.
Publicado: (2022)

Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis
por: Marquette, Malcolm, et al.
Publicado: (2022)

Patient-Reported Control of Asthma, Nasal Polyposis, and Middle-Ear Symptoms in NSAID-Exacerbated Respiratory Disease
por: Suikkila, Anna, et al.
Publicado: (2021)

Is TLR4 Critical for Neutrophil Apoptosis in Occupational Asthma?
por: Choi, Youngwoo, et al.
Publicado: (2020)

A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease
por: Pendolino, Alfonso Luca, et al.
Publicado: (2021)

Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics
por: Lee, Youngsoo, et al.
Publicado: (2019)

Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2011)

Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
por: Shin, Seung-Woo, et al.
Publicado: (2014)

Association of eosinophil‐derived neurotoxin levels with asthma control status in patients with aspirin‐exacerbated respiratory disease
por: Ban, Ga‐Young, et al.
Publicado: (2023)

Pulmonary Surfactants: a New Therapeutic Target in Asthma
por: Choi, Youngwoo, et al.
Publicado: (2020)

Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
por: Lyly, Annina, et al.
Publicado: (2021)

A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease
por: Losol, Purevsuren, et al.
Publicado: (2013)

Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease
por: Reigada-Rivera, María Luisa, et al.
Publicado: (2022)

Investigation of the Relationship between Aspirin-Sensitivity and Poor Response to Medical Management in NSAIDs-exacerbated Respiratory Disease Patients with Sinonasal Polyposis
por: Nabavi, Mohammad, et al.
Publicado: (2023)

Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease
por: Kwon, Eun-Kyung, et al.
Publicado: (2023)

S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma
por: Quoc, Quang Luu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1eo7tmba1v92jap7na9ofmmn5j